| Name | Title | Contact Details |
|---|
Manet Community Health Center is a non-profit health and social services provider that offers a range of medical and support services to South Shore residents.
Health Partners Plans is a health insurance organization serving more than 267,456 members in Southeastern Pennsylvania. Founded more than 30 years ago, Health Partners Plans offers Medicaid, Medicare and Children`s Health Insurance Program (CHIP) plans that include special benefits to improve the health and wellness of our members. We`re also committed to boosting the health of our community through outreach, education and events. Health Partners Plans is one of the few hospital-owned health maintenance organizations in the country. We continually develop new ways to encourage better health outcomes and have received national recognition for our innovations in managed care.
Welcome to your destination. Our mission is simple: to provide the best for your pet.
Beverly Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Montebello, CA. To find more information about Beverly Hospital, please visit www.beverly.org
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.